ES2136206T3 - Composicion antibacteriana que contiene alfalactalbumina multimerica. - Google Patents
Composicion antibacteriana que contiene alfalactalbumina multimerica.Info
- Publication number
- ES2136206T3 ES2136206T3 ES94928519T ES94928519T ES2136206T3 ES 2136206 T3 ES2136206 T3 ES 2136206T3 ES 94928519 T ES94928519 T ES 94928519T ES 94928519 T ES94928519 T ES 94928519T ES 2136206 T3 ES2136206 T3 ES 2136206T3
- Authority
- ES
- Spain
- Prior art keywords
- multimerica
- alfalactalbumina
- composition containing
- antibacterial composition
- lactalbumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
- A23J3/10—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/24—Extraction; Separation; Purification by electrochemical means
- C07K1/26—Electrophoresis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Electrochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
Abstract
LA PRESENTE INVENCION HACE REFERENCIA AL USO DE ALFALACTALBUMINA MULTIMERICA EN LA PREPARACION DE PREPARACIONES A USAR EN EL TRATAMIENTO TERAPEUTICO O PROFILACTICO Y/O PARA EL USO DIAGNOSTICO DE INFECCIONES, PREFERIBLEMENTE DEL TRACTO RESPIRATORIO, CAUSADAS POR BACTERIAS, EN PARTICULAR S. PNEUMONIAE Y/O H. INFLUENZAE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/SE1994/000742 WO1996004929A1 (en) | 1994-08-16 | 1994-08-16 | Antibacterial composition containing multimeric alpha-lactalbumin |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2136206T3 true ES2136206T3 (es) | 1999-11-16 |
Family
ID=20393168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94928519T Expired - Lifetime ES2136206T3 (es) | 1994-08-16 | 1994-08-16 | Composicion antibacteriana que contiene alfalactalbumina multimerica. |
Country Status (11)
Country | Link |
---|---|
US (2) | US6599874B1 (es) |
EP (1) | EP0776214B1 (es) |
JP (1) | JP3694319B2 (es) |
AT (1) | ATE182470T1 (es) |
AU (1) | AU7792294A (es) |
CA (1) | CA2197659C (es) |
DE (1) | DE69419782T2 (es) |
DK (1) | DK0776214T3 (es) |
ES (1) | ES2136206T3 (es) |
GR (1) | GR3031078T3 (es) |
WO (1) | WO1996004929A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5968901A (en) * | 1989-10-30 | 1999-10-19 | Andersson; Bengt | Antibacterial composition |
AU1254199A (en) | 1997-11-21 | 1999-06-15 | Per Anders Hakansson | Lactalbumin production process |
GB9724725D0 (en) * | 1997-11-21 | 1998-01-21 | Svanborg Catharina | Protein production process |
GB9725126D0 (en) * | 1997-11-27 | 1998-01-28 | Svanborg Catharina | Therapeutic agents |
US6815419B1 (en) * | 1999-07-28 | 2004-11-09 | Morinaga Milk Industry Co., Ltd. | Antiulcer agent |
AU2002356112B2 (en) * | 2001-08-23 | 2007-11-08 | Westgate Biological Limited | Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
GB0210464D0 (en) | 2002-05-08 | 2002-06-12 | Svanborg Catharina | Therapeutic treatment |
CN102590413B (zh) * | 2012-01-18 | 2013-12-25 | 浙江省疾病预防控制中心 | 一种牛α-乳白蛋白的定量检测方法 |
EP3295953B1 (en) | 2012-08-09 | 2020-10-21 | HAMLET Pharma AB | Milk protein - fatty acid complex |
WO2024075003A1 (en) | 2022-10-03 | 2024-04-11 | Linnane Pharma Ab | A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2459619B1 (fr) * | 1979-06-26 | 1983-07-29 | Agronomique Inst Nat Rech | Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede |
EP0058665B1 (en) | 1980-05-09 | 1986-02-26 | LEFFLER, Hakon | Carbohydrate derivatives for inhibiting bacterial adherence |
CA1333471C (en) * | 1988-04-29 | 1994-12-13 | Gustavo Bounous | Whey protein concentrate as food supplement |
US5968901A (en) * | 1989-10-30 | 1999-10-19 | Andersson; Bengt | Antibacterial composition |
US5795611A (en) | 1989-12-20 | 1998-08-18 | Slattery; Charles W. | Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein |
JP2961625B2 (ja) * | 1991-01-21 | 1999-10-12 | 雪印乳業株式会社 | α−ラクトアルブミン含有量の高い組成物の製造方法 |
-
1994
- 1994-08-16 DK DK94928519T patent/DK0776214T3/da active
- 1994-08-16 AT AT94928519T patent/ATE182470T1/de not_active IP Right Cessation
- 1994-08-16 ES ES94928519T patent/ES2136206T3/es not_active Expired - Lifetime
- 1994-08-16 JP JP50722496A patent/JP3694319B2/ja not_active Expired - Lifetime
- 1994-08-16 AU AU77922/94A patent/AU7792294A/en not_active Abandoned
- 1994-08-16 DE DE69419782T patent/DE69419782T2/de not_active Expired - Lifetime
- 1994-08-16 WO PCT/SE1994/000742 patent/WO1996004929A1/en active IP Right Grant
- 1994-08-16 EP EP94928519A patent/EP0776214B1/en not_active Expired - Lifetime
- 1994-08-16 CA CA002197659A patent/CA2197659C/en not_active Expired - Fee Related
-
1999
- 1999-08-26 GR GR990402161T patent/GR3031078T3/el unknown
-
2000
- 2000-08-17 US US09/639,938 patent/US6599874B1/en not_active Expired - Fee Related
-
2003
- 2003-07-11 US US10/617,093 patent/US7144855B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1996004929A1 (en) | 1996-02-22 |
DE69419782T2 (de) | 1999-12-23 |
US6599874B1 (en) | 2003-07-29 |
JPH10504547A (ja) | 1998-05-06 |
JP3694319B2 (ja) | 2005-09-14 |
CA2197659C (en) | 2009-11-10 |
DE69419782D1 (de) | 1999-09-02 |
EP0776214A1 (en) | 1997-06-04 |
ATE182470T1 (de) | 1999-08-15 |
GR3031078T3 (en) | 1999-12-31 |
EP0776214B1 (en) | 1999-07-28 |
DK0776214T3 (da) | 1999-11-29 |
CA2197659A1 (en) | 1996-02-22 |
US7144855B2 (en) | 2006-12-05 |
US20040106541A1 (en) | 2004-06-03 |
AU7792294A (en) | 1996-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1014155A1 (en) | Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic | |
DE3462255D1 (en) | Quinolone carboxylic acids, process for their preparation and antibacterial compositions containing them | |
MD970199A (en) | Induction of a cytotoxic T-lymphocytic answer The invention relates to the medicine, particularly to the immunology and can be used for treatment of bacterial and parasitic infections, tumors and other diseases. The summary of the invention consists in the induction of a cytotoxic T-lymphocytic answer to human and animals by means of a composition consisting of an antigene and an antigenic formulati | |
MY113059A (en) | Controlled-release dosage forms of azithromycin | |
MXPA02002895A (es) | Tratamiento topico de infecciones por estreptococcus. | |
BG101118A (en) | Therapeutical compounds | |
NZ251320A (en) | Bis-aromatic alpha,beta-unsaturated ketones, preparation and use in pharmaceutical compositions | |
PT806941E (pt) | Composicoes anti-bacterianas liposomicas de rigidez baixa | |
ES2136206T3 (es) | Composicion antibacteriana que contiene alfalactalbumina multimerica. | |
WO2000058475A3 (en) | Streptococcus pneumoniae antigens | |
TR199900661T2 (xx) | Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m� | |
SE8903625L (sv) | Antibacterial composition | |
NZ510153A (en) | Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals | |
NO951750L (no) | Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme | |
CA2351947A1 (en) | Hyperforin as cytostatic agent and hyperforin ointment or cream as application form | |
CLARKE | TOPICAL USE OF SILVER SULPHADIAZINE AND CHLORHEXIDINE IN THW PREVENTION OF INFECTION IN THERMAL INJURIES | |
ATE457730T1 (de) | Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen | |
Ginsburg | Streptococcus. | |
ME00858B (me) | UPOTREBA 8a-AZALIDA U VETERINI KAO ANTIMIKROBNA SREDSTVA | |
Lawrence | Infection control in burns | |
McDougall | Burns and the Use of Silver Sulphadiazine 1 | |
Lechi et al. | Clinical evaluation of ceftazidime in the treatment of infections caused by Pseudomonas and other gram-negative bacteria. | |
Kaye | Current News. | |
Meisel et al. | Efficacy of ciprofloxacin in bacterial infections of the skin. | |
IT1313628B1 (it) | Uso di compositi di fluorochinolone contro batteri dell'apparatorespiratorio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 776214 Country of ref document: ES |